Shirley Middlemost

4.2k total citations
23 papers, 556 citations indexed

About

Shirley Middlemost is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Shirley Middlemost has authored 23 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Cardiology and Cardiovascular Medicine, 7 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Shirley Middlemost's work include Cardiac Valve Diseases and Treatments (12 papers), Cardiovascular Function and Risk Factors (6 papers) and Infective Endocarditis Diagnosis and Management (6 papers). Shirley Middlemost is often cited by papers focused on Cardiac Valve Diseases and Treatments (12 papers), Cardiovascular Function and Risk Factors (6 papers) and Infective Endocarditis Diagnosis and Management (6 papers). Shirley Middlemost collaborates with scholars based in South Africa, United States and Belgium. Shirley Middlemost's co-authors include John Skoularigis, Pinhas Sareli, Thomas Wisenbaugh, Mohammed R. Essop, Rafique Essop, Daniel Skudicky, Pinhas Sareli, Christian Röthlisberger, Ivor Katz and Colin B. Meyerowitz and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and The American Journal of Cardiology.

In The Last Decade

Shirley Middlemost

23 papers receiving 532 citations

Peers

Shirley Middlemost
Shirley Middlemost
Citations per year, relative to Shirley Middlemost Shirley Middlemost (= 1×) peers Rikardo Krakover

Countries citing papers authored by Shirley Middlemost

Since Specialization
Citations

This map shows the geographic impact of Shirley Middlemost's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shirley Middlemost with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shirley Middlemost more than expected).

Fields of papers citing papers by Shirley Middlemost

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shirley Middlemost. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shirley Middlemost. The network helps show where Shirley Middlemost may publish in the future.

Co-authorship network of co-authors of Shirley Middlemost

This figure shows the co-authorship network connecting the top 25 collaborators of Shirley Middlemost. A scholar is included among the top collaborators of Shirley Middlemost based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shirley Middlemost. Shirley Middlemost is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abelson, Mark, André W. Phillips, & Shirley Middlemost. (2021). Nine-year, single-centre experience of left atrial appendage occlusion: patient characteristics, procedural outcomes and long-term follow up. Cardiovascular journal of South Africa. 32(1). 35–38. 1 indexed citations
2.
Middlemost, Shirley, et al.. (2012). Expert report on the 22nd European meeting on hypertension and cardiovascular protection, London, 26-29 April 2012.. PubMed. 23(4). 232–4. 3 indexed citations
3.
Rw, Frater, et al.. (2006). Quattro valve trial at mid-term: December 1996 to November 2004.. PubMed. 15(2). 230–7; discussion 237. 6 indexed citations
4.
Duncan, Ian C., et al.. (2004). Percutaneous endovascular occlusion of symptomatic coronary arteriovenous fistulas with cyanoacrylate.. PubMed. 16(9). 469–74. 1 indexed citations
5.
Middlemost, Shirley & Pravin Manga. (2003). The Quattro valve in rheumatic mitral valve disease: four-year follow up.. PubMed. 12(6). 758–63. 4 indexed citations
6.
Monterroso, Víctor H., Gustavo Aroca, G Hitzenberger, et al.. (2000). Use of ambulatory blood pressure monitoring to compare antihypertensive efficacy and safety of two angiotensin II receptor antagonists, losartan and valsartan. Advances in Therapy. 17(2). 117–131. 29 indexed citations
7.
Middlemost, Shirley & Pravin Manga. (1999). The stentless quadrileaflet bovine pericardial mitral valve: echocardiographic assessment.. PubMed. 8(2). 180–5. 8 indexed citations
8.
Middlemost, Shirley, et al.. (1994). Effectiveness of enalapril in combination with low-dose Hydrochlorothiazide versus enalapril alone for mild to moderate systemic hypertension in black patients. The American Journal of Cardiology. 73(15). 1092–1097. 30 indexed citations
9.
Wisenbaugh, Thomas, Ivor Katz, Rafique Essop, et al.. (1993). Long-term (3-month) effects of a new beta-blocker (nebivolol) on cardiac performance in dilated cardiomyopathy. Journal of the American College of Cardiology. 21(5). 1094–1100. 114 indexed citations
10.
Skoularigis, John, Mohammed R. Essop, Daniel Skudicky, Shirley Middlemost, & Pinhas Sareli. (1993). Frequency and severity of intravascular hemolysis after left-sided cardiac valve replacement with medtronic hall and St. Jude medical prostheses, and influence of prosthetic type, position, size and number. The American Journal of Cardiology. 71(7). 587–591. 66 indexed citations
11.
Wisenbaugh, Thomas, Rafique Essop, Shirley Middlemost, et al.. (1993). Pulmonary hypertension is a contraindication to β-blockade in patients with severe mitral stenosis. American Heart Journal. 125(3). 786–790. 8 indexed citations
12.
Wisenbaugh, Thomas, Rafique Essop, Shirley Middlemost, John Skoularigis, & Pinhas Sareli. (1992). Excessive vasoconstriction in rheumatic mitral stenosis with modestly reduced ejection fraction. Journal of the American College of Cardiology. 20(6). 1339–1344. 23 indexed citations
13.
Wisenbaugh, Thomas, Rafique Essop, Shirley Middlemost, et al.. (1992). Effects of severe pulmonary hypertension on outcome of balloon mitral valvotomy. The American Journal of Cardiology. 70(7). 823–825. 9 indexed citations
14.
Skoularigis, John, E Deviri, Thomas Wisenbaugh, et al.. (1992). Role of transesophageal echocardiography in diagnosis of subaortic aneurysm. The American Journal of Cardiology. 69(12). 1102–1104. 11 indexed citations
16.
Essop, Mohammed R., Shirley Middlemost, John Skoularigis, & Pinhas Sareli. (1992). Simultaneous mechanical clot fragmentation and pharmacologic thrombolysis in acute massive pulmonary embolism. The American Journal of Cardiology. 69(4). 427–430. 36 indexed citations
17.
Middlemost, Shirley, Thomas Wisenbaugh, Colin B. Meyerowitz, et al.. (1991). A case for early surgery in native left-sided endocarditis complicated by heart failure: Results in 203 patients. Journal of the American College of Cardiology. 18(3). 663–667. 97 indexed citations
18.
Wisenbaugh, Thomas, Michael Berk, Rafique Essop, Shirley Middlemost, & Pinhas Sareli. (1991). Effect of abrupt mitral regurgitation after balloon valvuloplasty on myocardial load and performance. Journal of the American College of Cardiology. 17(4). 872–878. 2 indexed citations
19.
Wisenbaugh, Thomas, Michael Berk, Rafique Essop, Shirley Middlemost, & Pinhas Sareli. (1991). Effect of mitral regurgitation and volume loading on pressure half-time before and after balloon valvotomy in mitral stenosis. The American Journal of Cardiology. 67(2). 162–168. 10 indexed citations
20.
Essop, Mohammed R., Thomas Wisenbaugh, John Skoularigis, Shirley Middlemost, & Pinhas Sareli. (1991). Mitral regurgitation following mitral balloon valvotomy. Differing mechanisms for severe versus mild-to-moderate lesions.. Circulation. 84(4). 1669–1679. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026